(ARCB) ArcBest - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03937C1053

LTL, Freight, Logistics, Transportation, Brokerage

Dividends

Dividend Yield 0.67%
Yield on Cost 5y 1.10%
Yield CAGR 5y 10.67%
Payout Consistency 75.3%
Payout Ratio 10.3%
Risk via 10d forecast
Volatility 50.0%
Value at Risk 5%th 70.5%
Relative Tail Risk -14.23%
Reward TTM
Sharpe Ratio -0.58
Alpha -55.81
CAGR/Max DD -0.03
Character TTM
Hurst Exponent 0.379
Beta 1.628
Beta Downside 1.234
Drawdowns 3y
Max DD 62.45%
Mean DD 26.01%
Median DD 24.47%

Description: ARCB ArcBest November 12, 2025

ArcBest Corp. (NASDAQ:ARCB) operates an integrated logistics network that delivers ground, air, and ocean freight worldwide through two distinct business models: an Asset-Based segment that runs a nationwide less-than-truckload (LTL) carrier serving a broad mix of commodities, and an Asset-Light segment that functions as a brokerage and value-added logistics provider, offering expedited, temperature-controlled, intermodal, warehousing, and final-mile services as well as international freight solutions.

Key quantitative touchpoints (as of FY 2023) include total revenue of roughly $2.4 billion, an adjusted EBITDA margin near 9 %, and a truckload utilization rate of about 84 %, which is modestly above the industry average of 80 % and reflects ongoing capacity tightening in the U.S. freight market. The business is sensitive to macro-level drivers such as e-commerce volume growth (projected to rise 10-12 % YoY) and fuel price volatility, both of which directly impact pricing power and cost structure in the LTL and brokerage segments.

For a deeper quantitative view, you may want to explore ValueRay’s platform for granular financial metrics and peer comparisons.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (97.2m TTM) > 0 and > 6% of Revenue (6% = 242.3m TTM)
FCFTA 0.03 (>2.0%) and ΔFCFTA 0.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -0.33% (prev 0.62%; Δ -0.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.10 (>3.0%) and CFO 241.1m > Net Income 97.2m (YES >=105%, WARN >=100%)
Net Debt (339.9m) to EBITDA (297.6m) ratio: 1.14 <= 3.0 (WARN <= 3.5)
Current Ratio 0.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (23.0m) change vs 12m ago -2.75% (target <= -2.0% for YES)
Gross Margin 7.64% (prev 8.98%; Δ -1.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 164.3% (prev 176.7%; Δ -12.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 12.46 (EBITDA TTM 297.6m / Interest Expense TTM 11.4m) >= 6 (WARN >= 3)

Altman Z'' 3.64

(A) -0.01 = (Total Current Assets 657.1m - Total Current Liabilities 670.5m) / Total Assets 2.50b
(B) 0.60 = Retained Earnings (Balance) 1.50b / Total Assets 2.50b
(C) 0.06 = EBIT TTM 142.5m / Avg Total Assets 2.46b
(D) 1.27 = Book Value of Equity 1.50b / Total Liabilities 1.18b
Total Rating: 3.64 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 44.47

1. Piotroski 4.50pt
2. FCF Yield 4.86%
3. FCF Margin 2.12%
4. Debt/Equity 0.35
5. Debt/Ebitda 1.14
6. ROIC - WACC (= -2.36)%
7. RoE 7.43%
8. Rev. Trend -87.47%
9. EPS Trend -61.98%

What is the price of ARCB shares?

As of December 07, 2025, the stock is trading at USD 71.19 with a total of 291,427 shares traded.
Over the past week, the price has changed by +10.94%, over one month by +0.79%, over three months by -5.78% and over the past year by -33.21%.

Is ARCB a buy, sell or hold?

ArcBest has received a consensus analysts rating of 3.69. Therefor, it is recommend to hold ARCB.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 6
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the ARCB price?

Issuer Target Up/Down from current
Wallstreet Target Price 81.4 14.4%
Analysts Target Price 81.4 14.4%
ValueRay Target Price 65.4 -8.1%

ARCB Fundamental Data Overview November 25, 2025

Market Cap USD = 1.44b (1.44b USD * 1.0 USD.USD)
P/E Trailing = 15.0119
P/E Forward = 11.655
P/S = 0.3556
P/B = 1.0758
P/EG = 3.0
Beta = 1.507
Revenue TTM = 4.04b USD
EBIT TTM = 142.5m USD
EBITDA TTM = 297.6m USD
Long Term Debt = 135.5m USD (from longTermDebt, last quarter)
Short Term Debt = 114.1m USD (from shortTermDebt, last quarter)
Debt = 460.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 339.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.76b USD (1.44b + Debt 460.5m - CCE 132.6m)
Interest Coverage Ratio = 12.46 (Ebit TTM 142.5m / Interest Expense TTM 11.4m)
FCF Yield = 4.86% (FCF TTM 85.8m / Enterprise Value 1.76b)
FCF Margin = 2.12% (FCF TTM 85.8m / Revenue TTM 4.04b)
Net Margin = 2.41% (Net Income TTM 97.2m / Revenue TTM 4.04b)
Gross Margin = 7.64% ((Revenue TTM 4.04b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 8.22% (prev 8.23%)
Tobins Q-Ratio = 0.71 (Enterprise Value 1.76b / Total Assets 2.50b)
Interest Expense / Debt = 0.72% (Interest Expense 3.33m / Debt 460.5m)
Taxrate = 26.60% (14.2m / 53.5m)
NOPAT = 104.6m (EBIT 142.5m * (1 - 26.60%))
Current Ratio = 0.98 (Total Current Assets 657.1m / Total Current Liabilities 670.5m)
Debt / Equity = 0.35 (Debt 460.5m / totalStockholderEquity, last quarter 1.32b)
Debt / EBITDA = 1.14 (Net Debt 339.9m / EBITDA 297.6m)
Debt / FCF = 3.96 (Net Debt 339.9m / FCF TTM 85.8m)
Total Stockholder Equity = 1.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 97.2m / Total Assets 2.50b)
RoE = 7.43% (Net Income TTM 97.2m / Total Stockholder Equity 1.31b)
RoCE = 9.87% (EBIT 142.5m / Capital Employed (Equity 1.31b + L.T.Debt 135.5m))
RoIC = 6.87% (NOPAT 104.6m / Invested Capital 1.52b)
WACC = 9.23% (E(1.44b)/V(1.90b) * Re(12.02%) + D(460.5m)/V(1.90b) * Rd(0.72%) * (1-Tc(0.27)))
Discount Rate = 12.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.53%
[DCF Debug] Terminal Value 57.86% ; FCFE base≈84.0m ; Y1≈61.6m ; Y5≈35.1m
Fair Price DCF = 17.42 (DCF Value 392.2m / Shares Outstanding 22.5m; 5y FCF grow -31.56% → 3.0% )
EPS Correlation: -61.98 | EPS CAGR: -15.86% | SUE: 0.10 | # QB: 0
Revenue Correlation: -87.47 | Revenue CAGR: -3.22% | SUE: 0.61 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.32 | Chg30d=-0.416 | Revisions Net=-5 | Analysts=8
EPS next Year (2026-12-31): EPS=5.10 | Chg30d=-1.179 | Revisions Net=-8 | Growth EPS=+35.8% | Growth Revenue=+3.5%

Additional Sources for ARCB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle